Indeed, the impact of obesity on female infertility is a topic of increasing importance in modern gynecological practice and extensive research is needed to reach well-defined guidelines. In this study, the effect of obesity on ovulatory functions in polycystic ovarian syndrome (PCOS) was evaluated in 80 PCOS patients attending the infertility outpatient clinic of Kasr Al-Aini hospital. Patients and methods A total of 80 PCOS patients were selected according to a restricted inclusion and exclusion criteria from Kasr Al-Aini infertility clinic during the period from July 2011 to March 2012; they were divided into three groups according to BMI: group A included 38 patients with BMI less than 30 kg/m 2 , group B included 24 patients with a BMI of 30-35 kg/m 2 , and group C included 18 patients with a BMI of 35-40 kg/m 2 . Ovulatory function inthe three groups was evaluated by folliculometry and evaluation of day 21 progesterone levels. Basal hormonal profile on day 2 of the cycle [folliclestimulating hormone, luteinizing hormone (LH), ethinyl estradiol, prolactin (PRL), and thyroid-stimulating hormone levels] was also evaluated and statistically analyzed.
Background
Indeed, the impact of obesity on female infertility is a topic of increasing importance in modern gynecological practice and extensive research is needed to reach well-defined guidelines. In this study, the effect of obesity on ovulatory functions in polycystic ovarian syndrome (PCOS) was evaluated in 80 PCOS patients attending the infertility outpatient clinic of Kasr Al-Aini hospital. Patients and methods A total of 80 PCOS patients were selected according to a restricted inclusion and exclusion criteria from Kasr Al-Aini infertility clinic during the period from July 2011 to March 2012; they were divided into three groups according to BMI: group A included 38 patients with BMI less than 30 kg/m 2 , group B included 24 patients with a BMI of 30-35 kg/m 2 , and group C included 18 patients with a BMI of 35-40 kg/m 2 . Ovulatory function inthe three groups was evaluated by folliculometry and evaluation of day 21 progesterone levels. Basal hormonal profile on day 2 of the cycle [folliclestimulating hormone, luteinizing hormone (LH), ethinyl estradiol, prolactin (PRL), and thyroid-stimulating hormone levels] was also evaluated and statistically analyzed.
Results
The results showed significant differences in the basal levels of LH and PRL (Po0.05) between the three groups; there was an inverse correlation between obesity and basal LH levels. The PRL level was also significantly higher in the nonobese groups. There was no significant difference in the basal level of follicle-stimulating hormone, ethinyl estradiol, and thyroid-stimulating hormone. With respect to ovulatory functions, the nonobese group showed better ovulatory performance especially when monitored in terms of day 21 progesterone levels (18.4% compared with 5.5% in the morbidly obese group). Conclusion Obesity in PCOS seems to increase the risk for anovulation, most probably through the disruption of the hypothalamo-pituitary axis by hyperandrogenism and/or insulin resistance. Leptin may play a role through its direct effect on folliculogenesis. Weight reduction in patients with PCOS may improve ovulatory performance. Monitoring ovulation by folliculometry alone may not reflect accurate ovarian response, and addition of assessment of day 21 progesterone levels should be considered to improve the evaluation. Further studies and randomized control trials are needed to justify this conclusion.
Introduction
Obesity is thought to result from a combination of environmental and genetic factors [1] . There are several methods for estimating body fat in adults, such as total body weight, waist circumference, and hip circumference. Several indices of obesity have been derived from these measurements, including BMI. BMI is the most widely used index of body fat with respect to body weight and height [2] .
According to the WHO classification of obesity, a BMI of over 35 could be associated with serious health risks [1] .
Obesity affects fertility through the development of functional hyperandrogenism, hyperinsulinemia, and an insulin resistant state, leading to increased free androgen availability and alterations in the granulosa cell functions and follicular development [3] .
Many studies have shown that many women with polycystic ovarian syndrome (PCOS; between 38 and 88%) are overweight or obese [4] . Obesity is suggested to play a specific pathophysiological role in the development of PCOS [5] .
The clinical features of PCOS are heterogeneous and may change throughout the lifespan, starting from adolescence to postmenopausal age [3] . Many definitions have been used to describe PCOS; however, the most commonly used definition in clinical practice is the Rotterdam criteria, which is used in the current study. In 2003 in Rotterdam, the Netherlands, a consensus meeting was held between the European Society of Human Reproduction and Embryology and the American Society for Reproductive Medicine (ESHRE/ASRM). 'The Rotterdam ESHRE/ASRM Consensus Workshop' defined PCOS. Affected individuals must fulfill two of the following three criteria: (i) oligo-ovulation and/or anovulation, (ii) hyperandrogenism (clinical and/or biochemical), and (iii) polycystic ovaries on sonographic examination, with one ovary being sufficient for diagnosis [6] .
Several studies have demonstrated higher rates of in-vitro fertilization (IVF) cycle cancellation before oocyte retrieval in overweight and obese women, especially in obese women with PCOS [7] [8] [9] . A higher cancellation rate of 25.3% was found in the morbidly obese group compared with 10.8% in normal weight and overweight women [10] .
The precise mechanisms for increased gonadotrophin requirements and a higher cancellation rate among obese women undergoing IVF remain unclear. However, it has been suggested that abnormal luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels may result in impaired ovarian response and decreased follicular maturation in this population [9] .
Indeed, the impact of obesity on female infertility is a topic of increasing importance in modern gynecological practice, and extensive research is needed to reach welldefined guidelines. In this study, the effect of obesity on ovulatory functions in PCOS was evaluated in three groups of women attending the infertility outpatient clinic of Kasr Al-Aini Hospital: group A, BMI less than 30 kg/m 2 ; group B, BMI between 30 and 34.9 kg/m 2 ; and group C, BMI between 35 and 40 kg/m 2 .
Patients and methods

Place
The study was conducted at Kasr Al-Aini infertility outpatient clinic, Cairo University, Egypt.
Design
This is a prospective comparative study conducted on 80 PCOS patients who underwent foliculometry and hormonal profiling for assessment of ovulation during the period from July 2011 to March 2012 at Kasr Al-Aini infertility outpatient clinic.
Inclusion criteria
(1) Age group: 20-35 years.
(2) Parity: variable.
(3) Diagnosis of PCOS according to the Rotterdam criteria. (4) Agreement for participation in the study.
Exclusion criteria
(1) Age less than 20 years or more than 35 years.
(2) A history of any disease that may affect ovulatory functions, such as thyroid, hepatic, or renal disease. (3) Previous operations on the ovary, such as ovarian drilling.
Written consents were obtained from all patients according to the code of clinical research ethics of Kasr Al-Aini hospitals.
Methods
All participants were subjected to the following evaluations:
(1) Complete history taking with special emphasis on age; parity; recent medications, especially with drugs that may affect ovulatory functions; and special habits of medical importance, for example, smoking. (2) Complete clinical examination including evaluation weight, height, and BMI, which was calculated as weight (in kg) divided by the height in meters squared [1] .
Patients were divided into three groups according to BMI as follows:
( Ovulation was induced in all participants by administration of 50 mg clomiphene citrate twice daily for 5 days starting on day 2 or 3. Metformin 500 mg tds was also administered for 1 month.
Ovulation was monitored in the three groups by serial sonography (Toshiba Famio 5 6 MHz, Tokyo, Japan) starting on day 9 or 10, and serum progesterone levels were measured on day 21. Ovulation was positive when the follicle size reached 16 mm or more (16-21 mm) or day 21 progesterone levels exceeded 12 ng/ml.
Basal hormonal levels [FSH, LH, ethinyl estradiol (E2), prolactin (PRL), and thyroid-stimulating hormone (TSH)] were also evaluated in the three groups, and the data were statistically analyzed using computer programs Microsoft Excel version 7 (Microsoft Corporation, Louisiana, USA) and SPSS (SPSS Inc., Chicago, Illinois, USA) version 15 for Microsoft windows.
Statistical analysis of the data
The results were analyzed by analysis of variance.
Results
The demographic data of the patients included in the study are presented in (Table 1 ). It is evident that there is no significant difference between the three groups as regards age or parity.
The basal hormonal profile on day 2 of the cycle is shown in (Table 2 . The results showed a significant difference in the basal levels of LH and PRL (Po0.05). No significant difference was observed in basal levels of FSH, E2, or TSH (P40.05).
Upon studying ovulation in the three groups of patients with different BMIs (Table 3) , it was found that ovulation was better in the nonobese group; however, this result did not show statistical significance (P40.05).
Upon studying ovulation in terms of day 21 progesterone levels (Table 4 ), it was obvious that ovulation was better in the nonobese group, and this result was statistically significant.
Discussion
Most of the studies on obesity and infertility are controversial, and this may be attributed to a vast array of factors such as type of the study, sample size, variation in methodology, and statistical analysis [11] .
The present study was conducted on 80 patients attending the infertility outpatient clinic of Kasr Al-Aini hospitals. They were divided according to their BMI into three groups: the first group had a BMI of less than 30, the second had a BMI of 30-35, and the third had a BMI of 35-40. With respect to the patient demographic data, there were no significant differences in age and parity among the three groups included -that is, patients were matched with respect to age and parity.
With respect to the basal hormonal profile, there was no significant difference in the day 2 levels of FSH, E2, and TSH between the three groups, but there was a statistically significant increase in day 2 LH and PRL levels in the nonobese group with a BMI of more than 30.
This inverse correlation between BMI and basal LH levels was observed in similar studies; this result was in agreement with that of the study by Pagán et al. [12] , who studied 24 women with PCOS across a spectrum of BMIs with frequent blood sampling, intravenous administration of gonadotrophin releasing hormone (GnRH) (75 ng/kg), and subcutaneous administration of the NAL-GLU GnRH antagonist (5 mg/kg) in the General Clinical Research Center of an academic hospital. They reported an inverse correlation between BMI and the mean LH and LH/FSH levels and the mean LH pulse amplitude. They also suggested that the effect of BMI on the LH level is mediated at a pituitary and not a hypothalamic level in PCOS, as they noticed that the pituitary response to a weight-based dose of GnRH is inversely related to BMI in patients with PCOS.
This conclusion was also arrived at by Bohlke et al. [13] , who assessed the relationship between BMI and the basal LH level; the LH-FSH ratio revealed the same inverse association between BMI and basal LH levels, but the study was conducted on normally menstruating women and not on PCOS patients.
However, Hill et al. [14] and Sathya et al. [15] , who studied the impact of BMI on the outcome of intracytoplasmic sperm injection cycles (they classified their patients only according to BMI without focusing on PCOS patients) stated in their results that the basal levels of LH did not differ between obese and lean women.
Our results also revealed significantly lower levels of PRL in the obese group compared with the nonobese group. This finding is also an important secondary outcome observed in this study.
As for basal FSH, E2, and TSH levels, the results showed no significant difference between the three groups with different BMIs. This result was in agreement with the findings of Sathya et al. [15] . In their study, which focused on the impact of obesity on IVF outcome, they recorded a nonsignificant difference in basal levels of hormones with different BMIs.
In contrast, our findings may disagree with those of other studies such as that by Loveland and colleagues, who carried out a retrospective analysis of 139 women younger than 40 years undergoing IVF cycles with fresh embryo transfers. They found that there is a decrease in the basal level of FSH in obese patients compared with nonobese patients [16] .
In addition, Giovanni and colleagues found lower basal FSH and estradiol levels in obese patients in their study, which was conducted on 22 patients with BMI greater than 30 to document the hormonal differences in obese women [17] .
In the second part of ourstudy, ovulation in the three groups was monitored by direct demonstration of growth of a follicle using transvaginal ultrasonography. Although ovulation seemed to be better in the nonobese group (23.6%), this result was not statistically significant. When ovulation was monitored in terms of day 21 progesterone levels, it was found to be was much better in the nonobese group (18.3%) compared with the other groups. Ovulation was worst in the morbidly obese group (5.5%).
Our results may agree with those of a prospective cohort study by Walter and colleagues. These authors found that in anovulatory women with PCOS resumption of ovulation was associated with early and consistent loss of intraabdominal fat (12.4 vs. 5 .0% at 3 months and 18.5 vs. 8.6% at 6 months) [18] .
There are also several studies that agree with our results, such as that by Norman et al., who concluded that there is a definite relationship between anovulation and BMI [19] .
Our results may be attributed to abnormal leptin levels in obese patients, which is believed to play a role in ovarian folliculogenesis. Human leptin is a protein made of 167 amino acids. It is synthesized primarily in the adipocytes of white adipose tissue, and the level of circulating leptin is directly proportional to the total amount of fat in the body [20] .
Leptin participates in the regulation of ovarian folliculogenesis indirectly by controlling LH and FSH secretion. More recent evidence suggests that leptin also has direct regulatory actions on the developing follicle. The presence of leptin receptors on follicular cells, including oocytes, and early preimplantation embryos suggests that leptin may play a direct physiologic role in follicular maturation and oocyte development [21] . Because circulating leptin levels are directly related to body adiposity, elevated leptin concentrations associated with obesity may partly explain the negative impact of obesity on ovulation through its effect on FSH secretion and its direct effect on the follicles.
There are several biological mechanisms through which obesity may increase the risk for anovulation. These mechanisms center on the hypothalamo-pituitary axis (HPO), which regulates both the menstrual cycle and ovulatory function through a complex hormonal regulation system. The two main disturbancesto the HPO axis are hyperandrogenism and insulin resistance [22] .
Hyperandrogenism is a biological condition in which there is excess production or secretion of androgens, which include sex hormones [3] . Adipose tissue has been shown to have the potential to alter the secretion of sex hormones, given its essential role in both androgen production and the conversion of androgens into other sex hormones [22] .
In the same manner, insulin resistance and hyperinsulinemia can lead to disturbances in ovulatory function. The ovary is a target organ for insulin to stimulate the production of sex hormones [22] . This increased insulin level will negatively affect follicular maturation by increasing free insulin-like growth factor 1 levels.
Conclusion
There is biological evidence supporting the hypothesis that obesity increases the risk for anovulation in PCOS patients through disruption of the HPO axis by hyperandrogenism and/or insulin resistance [22] , or through abnormal levels of leptin [21] . Therefore, weight reduction in PCOS patients may improve the ovulatory functions and should be advised along with the induction protocols. However, further research studies are still required to elucidate the roles of individual members of the complex endocrine system that controls these relationships.
